Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol 8:655–68. https://doi.org/10.1097/00000478-198409000-00005

Article  CAS  Google Scholar 

Volante M, Bussolati G, Papotti M (2016) The story of poorly differentiated thyroid carcinoma: From Langhans’ description to the Turin proposal via Juan Rosai. Semin Diagn Pathol 33:277–83. https://doi.org/10.1053/j.semdp.2016.05.007

Article  Google Scholar 

Tallini G (2011) Poorly differentiated thyroid carcinoma. Are we there yet? Endocr Pathol 22:190–4. https://doi.org/10.1007/s12022-011-9176-5

Article  CAS  Google Scholar 

Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–64. https://doi.org/10.1097/PAS.0b013e3180309e6a

Article  Google Scholar 

Xu B, David J, Dogan S, Landa I, Katabi N, Saliba M, Khimraj A, Sherman EJ, Tuttle RM, Tallini G, Ganly I, Fagin JA, Ghossein RA (2022) Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology 80:322–337. https://doi.org/10.1111/his.14550

Article  Google Scholar 

Xu B, Ghossein RA (2022) Advances in Thyroid Pathology: High Grade Follicular cell-derived Thyroid Carcinoma and Anaplastic Thyroid Carcinoma. Adv Anat Pathol.https://doi.org/10.1097/PAP.0000000000000380

Article  Google Scholar 

Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O (2022) Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33:27–63

Article  Google Scholar 

Gnemmi V, Renaud F, do Cao C, Salleron J, Lion G, Wemeau J-L, Copin M-C, Carnaille B, Leteurtre E, Pattou F, Aubert S (2014) Poorly differentiated thyroid carcinomas: application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features. Histopathology 64:263–73. https://doi.org/10.1111/his.12246

Article  Google Scholar 

Xu B, Ghossein R (2020) Poorly differentiated thyroid carcinoma. Semin Diagn Pathol 37:243–247. https://doi.org/10.1053/j.semdp.2020.03.003

Article  Google Scholar 

Sanders EM, LiVolsi VA, Brierley J, Shin J, Randolph GW (2007) An evidence-based review of poorly differentiated thyroid cancer. World J Surg 31:934–45. https://doi.org/10.1007/s00268-007-9033-3

Article  Google Scholar 

Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, Bussolati G, Lloyd RV (2010) Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol 23:1269–78. https://doi.org/10.1038/modpathol.2010.117

Article  Google Scholar 

Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta JA (2019) Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma. Thyroid 29:1255–1261. https://doi.org/10.1089/thy.2019.0263

Article  Google Scholar 

Wong KS, Barletta JA (2019) Thyroid Tumors You Don’t Want to Miss. Surg Pathol Clin 12:901–919. https://doi.org/10.1016/j.path.2019.08.008

Article  Google Scholar 

Cracolici V, Kadri S, Ritterhouse LL, Segal JP, Wanjari P, Cipriani NA (2019) Clinicopathologic and Molecular Features of Metastatic Follicular Thyroid Carcinoma in Patients Presenting With a Thyroid Nodule Versus a Distant Metastasis. American Journal of Surgical Pathology 43:514–522. https://doi.org/10.1097/PAS.0000000000001208

Article  Google Scholar 

Chernock RD, Rivera B, Borrelli N, Hill DA, Fahiminiya S, Shah T, Chong A-S, Aqil B, Mehrad M, Giordano TJ, Sheridan R, Rutter MM, Dehner LP, Foulkes WD, Nikiforov YE (2020) Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Mod Pathol 33:1264–1274. https://doi.org/10.1038/s41379-020-0458-7

Article  CAS  Google Scholar 

Wasserman JD, Sabbaghian N, Fahiminiya S, Chami R, Mete O, Acker M, Wu MK, Shlien A, de Kock L, Foulkes WD (2018) DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 103:2009–2015. https://doi.org/10.1210/jc.2017-02698

Article  Google Scholar 

Saliba M, Alzumaili BA, Katabi N, Dogan S, Tuttle RM, Zoltan A, Pandit-Taskar N, Xu B, Ghossein RA (2022) Clinicopathologic and Prognostic Features of Pediatric Follicular Cell-derived Thyroid Carcinomas: A Retrospective Study of 222 Patients. Am J Surg Pathol 46:1659–1669. https://doi.org/10.1097/PAS.0000000000001958

Article  Google Scholar 

Onder S, Mete O, Yilmaz I, Bayram A, Bagbudar S, Altay AY, Issin G, Terzi NK, Iscan Y, Sormaz IC, Tunca F, Senyurek YG, Yegen G (2022) DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection. Endocr Pathol 33:437–445. https://doi.org/10.1007/s12022-022-09736-y

Article  CAS  Google Scholar 

Juhlin CC, Stenman A, Zedenius J (2021) Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features. Histopathology 79:661–666. https://doi.org/10.1111/his.14416

Article  Google Scholar 

Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–55. https://doi.org/10.1002/1097-0142(19831115)52:10<1849::aid-cncr2820521015>3.0.co;2-x

Wong KS, Dong F, Telatar M, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Afkhami M, Barletta JA (2021) Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. Thyroid 31:933–940. https://doi.org/10.1089/thy.2020.0668

Article  CAS  Google Scholar 

Papotti M, Manazza AD, Chiarle R, Bussolati G (2004) Confocal microscope analysis and tridimensional reconstruction of papillary thyroid carcinoma nuclei. Virchows Arch 444:350–5. https://doi.org/10.1007/s00428-003-0962-4

Article  Google Scholar 

Baloch ZW, LiVolsi VA (2002) Etiology and significance of the optically clear nucleus. Endocr Pathol 13:289–99. https://doi.org/10.1385/ep:13:4:289

Article  Google Scholar 

Akslen LA, LiVolsi VA (2000) Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 88:1902–8

Article  CAS  Google Scholar 

Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah JP, Singh B, Ghossein RA (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106:1286–95. https://doi.org/10.1002/cncr.21739

Article  Google Scholar 

Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM (2008) Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer 113:48–56. https://doi.org/10.1002/cncr.23515

Article  Google Scholar 

Liu YF, Ahmed S, Bhuta S, Sercarz JA (2014) Infarction of papillary thyroid carcinoma after fine-needle aspiration: case series and review of literature. JAMA Otolaryngol Head Neck Surg 140:52–7. https://doi.org/10.1001/jamaoto.2013.5650

Article  Google Scholar 

Bolat F, Kayaselcuk F, Nursal TZ, Reyhan M, Bal N, Yildirim S, Tuncer I (2007) Histopathological changes in thyroid tissue after fine needle aspiration biopsy. Pathol Res Pract 203:641–5. https://doi.org/10.1016/j.prp.2007.05.004

Article  Google Scholar 

Cree IA, Tan PH, Travis WD, Wesseling P, Yagi Y, White VA, Lokuhetty D, Scolyer RA (2021) Counting mitoses: SI(ze) matters! Mod Pathol 34:1651–1657. https://doi.org/10.1038/s41379-021-00825-7

Article  Google Scholar 

Baloch ZW, LiVolsi VA (2018) Special types of thyroid carcinoma. Histopathology 72:40–52. https://doi.org/10.1111/his.13348

Article  Google Scholar 

Nath MC, Erickson LA (2018) Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid. Adv Anat Pathol 25:172–179. https://doi.org/10.1097/PAP.0000000000000184

Article  CAS  Google Scholar 

Pizzimenti C, Fiorentino V, Ieni A, Martini M, Tuccari G, Lentini M, Fadda G (2022) Aggressive variants of follicular cell-derived thyroid carcinoma: an overview. Endocrine 78:1–12. https://doi.org/10.1007/s12020-022-03146-0

Article  CAS  Google Scholar 

Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, Pötschke R, Mensch A, Bell JL, Dralle H, Siebolts U, Wickenhauser C, Lorenz K, Hüttelmaier S (2021) IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod Pathol 34:32–41. https://doi.org/10.1038/s41379-020-0630-0

Article  CAS  Google Scholar 

Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, Fagin JA, Ghossein RA (2010) Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 41:172–80. https://doi.org/10.1016/j.humpath.2009.08.011

Article  CAS  Google Scholar 

Cracolici V, Ritterhouse LL, Segal JP, Puranik R, Wanjari P, Kadri S, Parilla M, Cipriani NA (2020) Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas. American Journal of Surgical Pathology 44. https://doi.org/10.1097/PAS.0000000000001489

Rosenbaum JN, Guo Z, Baus RM, Werner H, Rehrauer WM, Lloyd RV (2015) INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms. Am J Clin Pathol 144:579–91. https://doi.org/10.1309/AJCPGZWXXBSNL4VD

Article  CAS  Google Scholar 

Toriyama A, Mori T, Sekine S, Yoshida A, Hino O, Tsuta K (2014) Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody. Histopathology 65:465–72. https://doi.org/10.1111/his.12405

Article  Google Scholar 

Liau J-Y, Tsai J-H, Jeng Y-M, Kuo K-T, Huang H-Y, Liang C-W, Yang C-Y (2016) The Diagnostic Utility of PAX8 for Neuroendocrine Tumors: An Immunohistochemical Reappraisal. Appl Immunohistochem Mol Morphol 24:57–63. https://doi.org/10.1097/PAI.0000000000000149

Article  CAS  Google Scholar 

Allison DB, Rueckert J, Cornea V, Lee CY, Dueber J, Bocklage T (2022) Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production. Endocr Pathol 33:315–326. https://doi.org/10.1007/s12022-021-09700-2

Article  CAS  Google Scholar 

Barletta JA, Gilday SD, Afkhami M, Bell D, Bocklage T, Boisselier P, Chau NG, Cipriani NA, Costes-Martineau V, Ghossein RA, Hertzler HJ, Kramer AM, Limaye S, Lopez CA, Ng TL, Weissferdt A, Xu B, Zhang S, French CA (2022) NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions. Am J Surg Pathol 46:1706–1715. https://doi.org/10.1097/PAS.0000000000001967

Article  Google Scholar 

Baloch Z, Mete O, Asa SL (2018) Immunohistochemical Biomarkers in Thyroid Pathology. Endocr Pathol 29:91–112. https://doi.org/10.1007/s12022-018-9532-9

Article  CAS  Google Scholar 

Soares P, Cameselle-Teijeiro J, Sobrinho-Simões M (1994) Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 24:205–10. https://doi.org/10.1111/j.1365-2559.1994.tb00511.x

Article  CAS  Google Scholar 

Hellgren LS, Stenman A, Paulsson JO, Höög A, Larsson C, Zedenius J, Juhlin CC (2022) Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center. Endocr Pathol 33:231–242. https://doi.org/10.1007/s12022-022-09714-4